Page 5 - Maat Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maat pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maat Pharma Today - Breaking & Trending Today

MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be Presented at the Upcoming EBMT Conference

LYON, France, March 12, 2024 Regulatory News: MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, will present extended results from its Early Access Program for patients with aGvHD that were treated with MaaT013 and, for the first time, Overall Survival data after 12 months in more patients. The data will be shared during an oral p ....

United States , Glasgow City , United Kingdom , Alexander Schauwvlieghe , Michael Loschi , Early Access Program , Corporate Communications , American Society Of Hematology , Meeting Of The European Society For Blood , Trophic Communications , Senior Pr Corporate Communications , Graft Vs Host Disease , Maat Pharma , Regulatory News , Microbiome Ecosystem , Overall Survival , Annual Meeting , European Society , Marrow Transplantation , Overall Response Rate , Nice Hospital , Oral Presentation , Microbiome Ecosystem Therapies , Euronext Paris , Investor Relations , Media Relations ,

MaaT Pharma : Inside Information / Other news releases -March 12, 2024 at 04:46 am EDT

Press release

MaaT Pharma Announces Long Term Follow-Up Data for MaaT013 in Early Access Program to be Presented at the Upcoming EBMT Conference

. ....

Alexander Schauwvlieghe , Senior Pr Corporate Communications , Trophic Communications , Early Access Program In Europe , Oral Presentation , Refractory Gastrointestinal , Early Access Program , Maat Pharma , Microbiome Ecosystem Therapies , Euronext Paris , Investor Relations ,

MaaT Pharma Announces Positive Review from the DSMB on the Ongoing Phase 1 Clinical Trial Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)

MaaT Pharma Announces Positive Review from the DSMB on the Ongoing Phase 1 Clinical Trial Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Lou Gehrig , Senior Pr Corporate Communications , European Medicines Agency , Trophic Communications , Independent Data Safety , Monitoring Board , Microbiome Ecosystem , Amyotrophic Lateral Sclerosis , Orphan Drug Designation , Maat Pharma , Microbiome Ecosystem Therapies , Euronext Paris , Investor Relations , Communications Manager ,

MaaT Pharma Announces Positive Review from the DSMB on the Ongoing Phase 1 Clinical Trial Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)

MaaT Pharma Announces Positive Review from the DSMB on the Ongoing Phase 1 Clinical Trial Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Lou Gehrig , European Medicines Agency , Microbiome Ecosystem , Orphan Drug Designation , Maat Pharma , Microbiome Ecosystem Therapies , Euronext Paris , Maat Pharma Stock ,

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Guilhaume Debroas , Stefan Klotter , Pauline Richaud , Trophic Communications , Regulations Of The Financial Markets Authority , Corporate Communications , General Regulations , Financial Markets Authority , Des March , Microbiome Ecosystem , French Commercial Code , French Autorit , Euronext Paris , Maat Pharma , Microbiome Ecosystem Therapies , Investor Relations , Die Performance Strategie , Assets Sie ,